Startseite>>Natural Products>>Tryptoquivaline D

Tryptoquivaline D (Synonyms: Nortryptoquivaline, NSC 292204)

Katalog-Nr.GC48442

Tryptoquivalin D ist ein Pilzmetabolit von Aspergillus fumigatus.

Products are for research use only. Not for human use. We do not sell to patients.

Tryptoquivaline D Chemische Struktur

Cas No.: 60676-56-4

Größe Preis Lagerbestand Menge
250µg
272,00 $
Auf Lager
1mg
981,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Tryptoquivaline D is a fungal metabolite that has been found in Neosartorya siamensis and has anticancer activity.1,2 It induces nuclear chromatin condensation, a marker of apoptosis, in HCT116 colon and HepG2 liver cancer cells when used at a concentration of 150 µM.1 Tryptoquivaline D (1-100 µM), alone or in combination with doxorubicin , reduces the viability of A549 lung cancer cells.2

1.Prata-Sena, M., Ramos, A.A., Buttachon, S., et al.Cytotoxic activity of secondary metabolites from marine-derived fungus Neosartorya siamensis in human cancer cellsPhytother. Res.30(11)1862-1871(2016) 2.Ramos, A.A., Castro-Carvalho , B., Prata-Sena, M., et al.Can marine-derived fungus Neosartorya siamensis KUFA 0017 extract and its secondary metabolites enhance antitumor activity of doxorubicin• An in vitro survey unveils interactions against lung cancer cellsEnviron. Toxicol.35(4)507-517(2020)

Bewertungen

Review for Tryptoquivaline D

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tryptoquivaline D

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.